James J Marino - Net Worth and Insider Trading
James J Marino Net Worth
The estimated net worth of James J Marino is at least $482,274 dollars as of 2024-05-26. James J Marino is the Director of Celldex Therapeutics Inc and owns about 12,704 shares of Celldex Therapeutics Inc (CLDX) stock worth over $469,032. James J Marino is also the Director of Traws Pharma Inc and owns about 21,334 shares of Traws Pharma Inc (TRAW) stock worth over $13,242. Details can be seen in James J Marino's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that James J Marino has not made any transactions after 2021-09-28 and currently still holds the listed stock(s).
Transaction Summary of James J Marino
James J Marino Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James J Marino owns 2 companies in total, including Traws Pharma Inc (TRAW) , and Celldex Therapeutics Inc (CLDX) .
Click here to see the complete history of James J Marino’s form 4 insider trades.
Insider Ownership Summary of James J Marino
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TRAW | Traws Pharma Inc | 2021-09-28 | director |
| CLDX | Celldex Therapeutics Inc | 2020-06-09 | director |
James J Marino Latest Holdings Summary
James J Marino currently owns a total of 2 stocks. Among these stocks, James J Marino owns 12,704 shares of Celldex Therapeutics Inc (CLDX) as of June 9, 2020, with a value of $469,032 and a weighting of 97.25%. James J Marino also owns 21,334 shares of Traws Pharma Inc (TRAW) as of September 28, 2021, with a value of $13,242 and a weighting of 2.75%.
Latest Holdings of James J Marino
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CLDX | Celldex Therapeutics Inc | 2020-06-09 | 12,704 | 36.92 | 469,032 |
| TRAW | Traws Pharma Inc | 2021-09-28 | 21,334 | 0.62 | 13,242 |
Holding Weightings of James J Marino
James J Marino Form 4 Trading Tracker
According to the SEC Form 4 filings, James J Marino has made a total of 1 transactions in Celldex Therapeutics Inc (CLDX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Celldex Therapeutics Inc is the acquisition of 8,305 shares on June 9, 2020, which cost James J Marino around $24,915.
According to the SEC Form 4 filings, James J Marino has made a total of 5 transactions in Traws Pharma Inc (TRAW) over the past 5 years, including 5 buys and 0 sells. The most-recent trade in Traws Pharma Inc is the acquisition of 5,952 shares on September 28, 2021, which cost James J Marino around $24,998.
Insider Trading History of James J Marino
- 1
James J Marino Trading Performance
GuruFocus tracks the stock performance after each of James J Marino's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by James J Marino is 105.13%. GuruFocus also compares James J Marino's trading performance to market benchmark return within the same time period. The performance of stocks bought by James J Marino within 3 months outperforms 3 times out of 8 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how James J Marino's insider trading performs compared to the benchmark.
Performance of James J Marino
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 55.06 | | | | | |
| Relative Return to S&P 500(%) | 53.39 | | | | | |
James J Marino Ownership Network
James J Marino Owned Company Details
What does Traws Pharma Inc do?
Who are the key executives at Traws Pharma Inc?
James J Marino is the director of Traws Pharma Inc. Other key executives at Traws Pharma Inc include CHIEF MEDICAL OFFICER Victor M Moyo , VP Corp Dev & Gen Counsel Abraham N. Oler , and Chief Medical Officer Steven M Fruchtman .
Traws Pharma Inc (TRAW) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Traws Pharma Inc (TRAW) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Traws Pharma Inc (TRAW) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Traws Pharma Inc (TRAW)'s detailed insider trading history can be found in Insider Trading Tracker table.
Traws Pharma Inc Insider Transactions
James J Marino Mailing Address
Above is the net worth, insider trading, and ownership report for James J Marino. You might contact James J Marino via mailing address: C/o Onconova Therapeutics, 375 Pheasant Run, Newtown Pa 18940.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
